Literature DB >> 22226098

Subsequent malignant neoplasms after hematopoietic cell transplantation.

Gerard Socié1, K Scott Baker, Smita Bhatia.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22226098      PMCID： PMC3260455          DOI： 10.1016/j.bbmt.2011.10.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  95 in total

1.  Second cancers after pediatric Hodgkin's disease.

Authors:  S Bhatia; A T Meadows; L L Robison
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544

2.  XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages.

Authors:  N Liu; J E Lamerdin; R S Tebbs; D Schild; J D Tucker; M R Shen; K W Brookman; M J Siciliano; C A Walter; W Fan; L S Narayana; Z Q Zhou; A W Adamson; K J Sorensen; D J Chen; N J Jones; L H Thompson
Journal:  Mol Cell       Date:  1998-05       Impact factor: 17.970

3.  Xrcc3 is required for assembly of Rad51 complexes in vivo.

Authors:  D K Bishop; U Ear; A Bhattacharyya; C Calderone; M Beckett; R R Weichselbaum; A Shinohara
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

4.  Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein.

Authors:  Y Kubota; R A Nash; A Klungland; P Schär; D E Barnes; T Lindahl
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

5.  Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.

Authors:  T Duell; M T van Lint; P Ljungman; A Tichelli; G Socié; J F Apperley; M Weiss; A Cohen; E Nekolla; H J Kolb
Journal:  Ann Intern Med       Date:  1997-02-01       Impact factor: 25.391

6.  Solid cancers after bone marrow transplantation.

Authors:  R E Curtis; P A Rowlings; H J Deeg; D A Shriner; G Socíe; L B Travis; M M Horowitz; R P Witherspoon; R N Hoover; K A Sobocinski; J F Fraumeni; J D Boice
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

Review 7.  Role of the human RAD51 protein in homologous recombination and double-stranded-break repair.

Authors:  P Baumann; S C West
Journal:  Trends Biochem Sci       Date:  1998-07       Impact factor: 13.807

8.  Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.

Authors:  H J Deeg; G Socié; G Schoch; M Henry-Amar; R P Witherspoon; A Devergie; K M Sullivan; E Gluckman; R Storb
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

9.  Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage.

Authors:  J Y Park; M K Shigenaga; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  Malignant neoplasms following bone marrow transplantation.

Authors:  S Bhatia; N K Ramsay; M Steinbuch; K E Dusenbery; R S Shapiro; D J Weisdorf; L L Robison; J S Miller; J P Neglia
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113
View more
  12 in total

1.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

Review 2.  Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.

Authors:  Minoo Battiwalla; André Tichelli; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-03       Impact factor: 5.742

3.  Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study.

Authors:  Hesham M Eissa; Lu Lu; Malek Baassiri; Nickhill Bhakta; Matthew J Ehrhardt; Brandon M Triplett; Daniel M Green; Daniel A Mulrooney; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  Blood Adv       Date:  2017-11-07

4.  Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.

Authors:  Yasushi Ishida; Dongmei Qiu; Miho Maeda; Junichiro Fujimoto; Hisato Kigasawa; Ryoji Kobayashi; Maho Sato; Jun Okamura; Shinji Yoshinaga; Takeshi Rikiishi; Hiroyuki Shichino; Chikako Kiyotani; Kazuko Kudo; Keiko Asami; Hiroki Hori; Hiroshi Kawaguchi; Hiroko Inada; Souichi Adachi; Atsushi Manabe; Tatsuo Kuroda
Journal:  Int J Clin Oncol       Date:  2015-11-30       Impact factor: 3.402

5.  Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.

Authors:  J D Pole; D Darmawikarta; A Gassas; M Ali; M Egler; M L Greenberg; J Doyle; P C Nathan; T Schechter
Journal:  Bone Marrow Transplant       Date:  2015-02-23       Impact factor: 5.483

6.  Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up.

Authors:  M Wilhelmsson; A Vatanen; B Borgström; B Gustafsson; M Taskinen; U M Saarinen-Pihkala; J Winiarski; K Jahnukainen
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

Review 7.  Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia.

Authors:  Anita Lawitschka; Christina Peters
Journal:  Curr Oncol Rep       Date:  2018-08-03       Impact factor: 5.075

Review 8.  Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.

Authors:  Lois B Travis; Wendy Demark Wahnefried; James M Allan; Marie E Wood; Andrea K Ng
Journal:  Nat Rev Clin Oncol       Date:  2013-03-26       Impact factor: 66.675

Review 9.  Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.

Authors:  Eric J Chow; Lynnette Anderson; K Scott Baker; Smita Bhatia; Gregory M T Guilcher; Jennifer T Huang; Wendy Pelletier; Joanna L Perkins; Linda S Rivard; Tal Schechter; Ami J Shah; Karla D Wilson; Kenneth Wong; Satkiran S Grewal; Saro H Armenian; Lillian R Meacham; Daniel A Mulrooney; Sharon M Castellino
Journal:  Biol Blood Marrow Transplant       Date:  2016-01-21       Impact factor: 5.742

10.  Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation.

Authors:  Megan M Herr; Rochelle E Curtis; Margaret A Tucker; Heather R Tecca; Eric A Engels; Elizabeth K Cahoon; Minoo Battiwalla; David Buchbinder; Mary E Flowers; Ruta Brazauskas; Bronwen E Shaw; Lindsay M Morton
Journal:  J Am Acad Dermatol       Date:  2019-10-22       Impact factor: 11.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.